June Ho Shin

1.5k total citations
33 papers, 894 citations indexed

About

June Ho Shin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, June Ho Shin has authored 33 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Immunology. Recurrent topics in June Ho Shin's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). June Ho Shin is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). June Ho Shin collaborates with scholars based in United States, South Korea and India. June Ho Shin's co-authors include John B. Sunwoo, Holbrook E. Kohrt, Yunqin Lee, Michelle Longmire, Hua Wang, Howard Y. Chang, Oihana Murillo, Mikel D. Haggadone, Jack D. Bui and Luhua Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

June Ho Shin

30 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
June Ho Shin United States 15 391 339 319 136 68 33 894
Daniela Murtas Italy 18 325 0.8× 250 0.7× 313 1.0× 106 0.8× 64 0.9× 38 855
Chamutal Bornstein Israel 9 456 1.2× 480 1.4× 269 0.8× 119 0.9× 47 0.7× 10 986
Kirsten Canté-Barrett Netherlands 17 529 1.4× 346 1.0× 221 0.7× 92 0.7× 35 0.5× 33 1.1k
Susana Galli United States 14 357 0.9× 226 0.7× 331 1.0× 115 0.8× 47 0.7× 29 862
Yupeng Wang China 10 266 0.7× 369 1.1× 265 0.8× 167 1.2× 25 0.4× 17 788
Giuliana P. Mognol Brazil 10 400 1.0× 291 0.9× 255 0.8× 89 0.7× 34 0.5× 14 750
Laura Bonapace Switzerland 9 560 1.4× 428 1.3× 406 1.3× 148 1.1× 41 0.6× 10 1.2k
Dai Liu China 15 366 0.9× 199 0.6× 170 0.5× 174 1.3× 49 0.7× 37 723
Marta Roche-Molina Spain 11 398 1.0× 251 0.7× 105 0.3× 131 1.0× 106 1.6× 18 851
Osman N. Özeş United States 13 649 1.7× 334 1.0× 269 0.8× 364 2.7× 55 0.8× 31 1.1k

Countries citing papers authored by June Ho Shin

Since Specialization
Citations

This map shows the geographic impact of June Ho Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June Ho Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June Ho Shin more than expected).

Fields of papers citing papers by June Ho Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June Ho Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June Ho Shin. The network helps show where June Ho Shin may publish in the future.

Co-authorship network of co-authors of June Ho Shin

This figure shows the co-authorship network connecting the top 25 collaborators of June Ho Shin. A scholar is included among the top collaborators of June Ho Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June Ho Shin. June Ho Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohammad, Imran, et al.. (2025). An intraepithelial ILC1-like natural killer cell subset produces IL-13. Frontiers in Immunology. 16. 1521086–1521086.
2.
Brennan, Kevin, Almudena Espín-Pérez, Serena Chang, et al.. (2023). Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. Genome Medicine. 15(1). 98–98. 3 indexed citations
3.
Shin, June Ho, Zhuoqing Fang, Kevin Brennan, et al.. (2023). Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma. Cancer Research. 83(16). 2645–2655. 10 indexed citations
4.
Kim, Min Young, June Ho Shin, Mi Ae Park, et al.. (2023). SUMOylation-mediated PSME3-20 S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression. Science Advances. 9(4). eadd4969–eadd4969. 11 indexed citations
5.
Shin, June Ho, et al.. (2021). AHR Regulates NK Cell Migration via ASB2–Mediated Ubiquitination of Filamin A. Frontiers in Immunology. 12. 624284–624284. 24 indexed citations
6.
Khan, Syamantak, June Ho Shin, Valentina Ferri, et al.. (2021). High-resolution positron emission microscopy of patient-derived tumor organoids. Nature Communications. 12(1). 5883–5883. 14 indexed citations
7.
Nguyen, Dang, Thanh Thao Nguyen, Vu Huynh, et al.. (2019). Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF‐90‐mediated ribosomal RNA synthesis. Journal of Cellular Physiology. 234(10). 17612–17621. 11 indexed citations
8.
Schoppy, David W., et al.. (2018). Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma. Otolaryngology. 159(1). 76–84. 14 indexed citations
9.
Chung, Man Ki, Young Ho Jung, Joon Kyoo Lee, et al.. (2017). CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug. Clinical Cancer Research. 24(3). 674–683. 39 indexed citations
10.
Kim, Jeewon, June Ho Shin, Che‐Hong Chen, et al.. (2017). Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor. Oncotarget. 8(32). 52345–52356. 42 indexed citations
11.
Brennan, Kevin, June Ho Shin, Joshua K. Tay, et al.. (2017). NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma. Scientific Reports. 7(1). 17064–17064. 73 indexed citations
12.
Lee, Yunqin, June Ho Shin, Michelle Longmire, et al.. (2016). CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1. Clinical Cancer Research. 22(14). 3571–3581. 179 indexed citations
13.
Shin, June Ho, Mikel D. Haggadone, & John B. Sunwoo. (2016). Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activity. Biochemistry and Biophysics Reports. 7. 353–360. 5 indexed citations
14.
Chen, Chen, et al.. (2016). ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma. Oncotarget. 7(43). 70738–70749. 18 indexed citations
15.
Lin, Zhaoyu, Zhenyu Sun, June Ho Shin, et al.. (2012). Reprogramming of Single-Cell–Derived Mesenchymal Stem Cells Into Hair Cell-Like Cells. Otology & Neurotology. 33(9). 1648–1655. 12 indexed citations
16.
Janisiewicz, Agnieszka M., June Ho Shin, Oihana Murillo, et al.. (2012). CD44+ cells have cancer stem cell–like properties in nasopharyngeal carcinoma. International Forum of Allergy & Rhinology. 2(6). 465–470. 31 indexed citations
17.
Kang, Ho Chul, Won Kim, Dae Hyun Ha, et al.. (2010). PIAS1 regulates CP2c localization and active promoter complex formation in erythroid cell-specific α-globin expression. Nucleic Acids Research. 38(16). 5456–5471. 13 indexed citations
18.
Shin, June Ho, Ho Chul Kang, Dae Hyun Ha, et al.. (2010). Corepressor MMTR/DMAP1 is an intrinsic negative regulator of CAK kinase to regulate cell cycle progression. Biochemical and Biophysical Research Communications. 402(1). 110–115. 4 indexed citations
19.
Shin, June Ho, Krzysztof Hyrc, Su Liu, et al.. (2006). Stem Cell Therapy for Hearing Loss. Otology & Neurotology. 27(3). 414–421. 11 indexed citations
20.
Shin, June Ho, Young Joon Lee, Ae Ryoung Kim, et al.. (2003). Development of artificial chimerical gene regulatory elements specific for cancer gene therapy. Oncology Reports. 10(6). 2063–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026